chrisvoncsefalvay/vaers-outcomes huggingface dataset:
light symptoms; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (light symptoms) and COVID-19 (COVID-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (light symptoms) and COVID-19 (COVID-19). At the time of the report, IMMUNISATION REACTION (light symptoms) and COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  No treatment information was provided by the reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
High platelet count; Thrombocytosis; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PLATELET COUNT INCREASED (High platelet count) and THROMBOCYTOSIS (Thrombocytosis) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 025l20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN+HCT) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Jun-2021, the patient experienced PLATELET COUNT INCREASED (High platelet count) and THROMBOCYTOSIS (Thrombocytosis). At the time of the report, PLATELET COUNT INCREASED (High platelet count) and THROMBOCYTOSIS (Thrombocytosis) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2014, Platelet count: 303 (Inconclusive) 303. In February 2016, Platelet count: 307 (Inconclusive) 307. In May 2021, Platelet count: 792 (Inconclusive) 792. In June 2021, Platelet count: 867 (Inconclusive) 867.         The patient consulted a Hematologist and was diagnosed with thrombocytosis.  The patient received both scheduled doses of mRNA-127 prior to the events, therefore action taken with the drug in response to the events as not applicable.  No treatment information was provided by the reporter.
ON THE SENCOND DAY AFTER THE VACCINE ,THAT NIGHT MY RIGHT EYE SWELLED UP TO ALMOST CLOSING. BY MORNING MY WHOLE FACE WAS SWOLLEN AND I HAD A HEADACHE. IT WAS THAT WAY UNTIL SUNDAY MORNING I REPROTED IT . EVERYDAY  I WAS ON BENDARYL FOR AROUND THE CLOCK FOR THOSE DAYS.
Information has been received from a physician concerning a female patient who was vaccinated with the first 0.5 ml dose of GARDASIL. Subsequently the patient experienced fainted. On approximately 6-NOV-2007, the patient received the second 0.5 ml dose of GARDASIL (lot # 658222/0927U). The patient experienced light headed and vomited. Therapy with GARDASIL was discontinued on 6-NOV-2007. On 6-NOV-2007, the patient recovered. The patient sought unspecified medical attention. Additional information has been requested.
Shortness of breath, dizziness, fever, redness, swelling, warmth at injection site, fasciitis over left deltoid muscle, early myositis
After the patient received the vaccine, she was feeling anxious and felt some heaviness in her arm. I advised that she sit in the chair in our clinical room since she was not feeling well. After sitting for approximately 5 minutes and feeling better, when she stood up and walked to the door, she started feeling nauseous and had syncope.
Pt noted reddness and swelling that resolved several days later with routine icing and continuing nerve pain and soreness radiating into fingers and hand of the effected arm for several week
A non-serious spontaneous report of administration of expired FLUMIST was received from a health professional concerning a four-year-old male. Neither the patient's medical history nor the concomitant medications have been  reported for this patient. The product expired on 15-Jan-2012. On 24-Jan-2012, expired FLUMIST was administered to the patient. There was no adverse event associated with this medication error, therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of two years to 59 months of age. Additional information was received on 09-Apr-2012: The patient did not develop any late occurring adverse events.
Information has been received from a nurse practitioner concerning a patient who was vaccinated with the second dose of VARIVAX (Merck) (lot #657449/0597U, route and site of administration not reported).  On unspecified date, the patient developed an immediate reaction at the injection site of redness, warmth, itching and burning.  The patient's outcome was unknown.  Follow up information has been received from the nurse practitioner concerning the patient with no pre-existing allergies or medical conditions who on an unspecified date developed immediate injection site redness, swelling, itching and burning after vaccination with VARIVAX (Merck).  There was no illness at time of vaccination.  The patient did not seek medical attention.  At the time of this report, the patient's outcome was unknown.  This is one of several cases from the same source.  Additional information is not expected.
Reported onset of headache about 10-15 minutes after injection given. Also complained of arm "aching" and pain down right arm. Rated pain as a "5" on pain scale of 0 to 10. Took 2 Motrin around 9 am which has helped the headache and sore arm. Right deltoid area with swelling, redness and warmth. Physician follow up call "no headache, arm just sore", but better.
Was treated as a stroke patient in the emergency room. Facial paralysis with extreme vertigo and nausea. Started at 10 pm the night before. As the symptoms became worse and unbearable.. was taken to Emergency department at 5pm ish on 05/18/2021
Patient noticed redness and swelling evening following vaccination. Over next 48 hours arm became warm and redness became larger covering area below shot down to elbow.
patient received the  Moderna Covid-19  vaccine   for her second dose but received the Pfizer covid 19 vaccine as her first dose. No adverse events have occured
pt recvd vax & 1 wk later exp rash on both forearms;
Fever accompanies by chills, headache, and body aches developed within 12 hours of receiving the vaccine and lasted for about 20 hours
Dx w/intuss 8 days post vax; reduced by air contrast enema;pt recovered doing fine;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 72-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 at 11:30 as dose 5 (booster), single (Lot number: GH9402) at the age of 72 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 03Feb2021 at 10:30 as dose 1, single (Lot number: EL9264), on 24Feb2021 at 10:30 as dose 2, single (Lot number: EN6203), on 14Oct2021 at 11:00 as dose 3 (booster), single (Lot number: FF2590), in left arm and on 07Apr2022 at 11:00 as dose 4 (booster), single (Lot number: FJ6369), in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: TYLENOL, start date: 20Jan2023, stop date: 24Jan2023. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), all with latency 1 year 11 months 28 days 13 hrs 30 min after the suspect product(s) administration, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30Jan2023) Negative; (01Feb2023) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient was received Paxlovid as treatment from 22Jan2023 to 27Jan2023. Medication received within 2 weeks is Tylenol from 20Jan2023 to 24Jan2023.  No follow-up attempts are possible. No further information is expected.
RN accidentally administered MMRV instead of just MMR in addition to a Varicella vaccine.  Pt received double dose of Varicella. Patient's family was notified and follow up visit scheduled.  No adverse side effects noted at the time of reporting error.
COVID + 10/16/22  - Vaccinated with pfizer x4 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge:  Admission Date: 10/16/2022 Discharge Date: 10/19/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dehydration [E86.0] Hypokalemia [E87.6] Generalized weakness [R53.1] Diarrhea, unspecified type [R19.7] COVID-19 virus detected [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 77 y.o. female who presents to hospital with weakness.  Patient reports developing cough approximately 4 days ago.  She began to be increasingly weak at this time with poor appetite and diarrhea.  She was unable to get off of her couch and was found in urine and stool at her home.  She was brought to the emergency department for evaluation.  She was afebrile, hemodynamically stable and not hypoxic.  Lab evaluation revealed a hypokalemia with normal magnesium level.  LFTs were elevated an EKG showed a significantly prolonged QT interval.  She denied of any nausea vomiting in the emergency department.  She was cleaned up by the nursing staff and bolused with IV fluids and given oral and IV potassium.  COVID testing was found to be positive and chest x-ray was negative.  Because of her weakness and severe electrolyte deficiency she was referred to the hospital for further evaluation and care.   Patient was given fluids and potassium was replaced.  The following day her electrolytes were stable but she remained very weak.  She was evaluated by Physical and Occupational therapy and felt to be a candidate for subacute rehab.  Patient was initially resistant to the idea of rehab however we did re-evaluate her for potential discharge home with home health therapy and she was unable to participate enough to make this option viable.  Care management found a COVID bed for her at hospital and she was subsequently discharged there to undergo physical therapy in a subacute rehab environment.  Her COVID symptoms never presented.  Her mild transaminitis is resolving.  We are going to discontinue her statin therapy at this point.  She was seen on the day of discharge doing well and discharged to assured in subacute rehab facility in stable condition
Pt recvd 1st & 2nd dose of vax 02NOV90 & 05DEC90 & recvd 3rd dose 20JAN91 & on 11MAY91 exp violent chest pain while playing football; Hospitalized & a myocardial infarction was dx following ECG; MD felt poss due to vax;
Starting on Wednesday November 9, 2022, I woke up really tired. As the week went on I developed a cough, and I was not feeling really good. On Friday I went to the doctor, and I had a really deep cough. They told me I had a virus. I was prescribed TESSALON and told to rest and drink plenty of water. On the weekend I did not feel much better. As of today, I am feeling better. I still have the cough and it is deep from my chest.
Swelling  on left side of face, which is same side as injection, and itching reported starting 3 hours after vaccine administration; patient also reports improving symptoms with decreased swelling and itching 24 hours later.
Patient claims that around 6:30 she expereinced a dry mouth and her "throat felt funny".  By 7:30, she started to feel chest tightness, so she had someone drive her to the emergency room.  She was seen around 10pm, given an EKG, chest X ray and "gave blood samples to rule out a heart attack".  She was prescribed prednisone, famotidine and zyrtec for a suspected allergic reaction to her flu shot and instructed by the ER doctor to not get a flu shot in the future.
Patient is complaining of a vesicular rash on her abdomen. A few of the lesions have crusted over and it is very itchy. She used topical Benadryl with no relief.
little pain and itchiness by the injection site; little pain and itchiness by the injection site; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A female patient of an unspecified age received second dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration on 13Feb2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced little pain and itchiness by the injection site on an unspecified date. The outcome of the event was unknown.  Information about lot/Batch number has been requested.  Follow-up attempts are completed. No further information is expected.
pt says she got real hot and sweaty.  She is pouring sweat  She got very light headed and dizzy so had to have help standing.  She got nauseated and had sharp pains in the right side of her abdomen.  Pt started vomiting.  She still has stomach cramps and is not sweating as much at this time.
Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Anaphylaxis-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Abdominal Pain-Mild, Systemic: Autoimmune Disease (diagnosed by MD)-Mild, Systemic: Bell's Palsy-Mild, Systemic: Blood Disorder  (diagnosed by MD)-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Cardiac Disorder (diagnosed by MD)-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Diarrhea-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Fever-Mild, Systemic: PREVIOUS EVENT EFFECTING LOT-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Heart Attack-Mild, Systemic: Hypertension-Mild, Systemic: Hyperventilation-Mild, Systemic: Hypotension-Mild, Systemic: Joint Pain-Mild, Systemic: Lymph Node Swelling-Mild, Systemic: MIS (Multisystem Inflammatory Syndrome)(diagnosed by MD)-Mild, Systemic: Nausea-Mild, Systemic: Neurological Disorder (diagnosed by MD)-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Seizure-Mild, Systemic: Shakiness-Mild, Systemic: Stroke-Mild, Systemic: Tachycardia-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Tinnitus-Mild, Systemic: Unable to Sleep-Mild, Systemic: Visual Changes/Disturbances-Mild, Systemic: Vomiting-Mild, Systemic: Weakness-Mild, Additional Details: PEARL RIVER RX HAS NOTIFIED EACH PATIENT INDIVIDUALLY AND WE ATTEST WE HAVE FOLLOWED THE COMPANY DIRECTION FOR PATIENT NOTIFICATION
8 hours after shot developed very strong cough, persisted all night, not too bed during day, bad could not sleep at night, persisted for all week, Went to care facility on 02/22 and got pretneson  for 5 day dose,it worked. then cough came back. went back to care facility 03/12, got antibiotics and more pretneson and narcotic cough syrup, I feel much better as of 03/15, Very little cough and sleeping well. This has worked. Just got 2nd does of moderna today. I was diagnosed with covid 11/302020, did ok with advil cold and sinus for 2 weeks, then cough started and  01/03/2021 was in hosptal with blood ox 83, 2 doses of antibiotics and pills to make me cough and I was out of there in 1 day, back up to 92 on blood ox, They gave very strong steriod for 7 days at home, it worked until events above.  I felt good until  02/15/2021.
This spontaneous report as received from a pharmacy technician refers to a 39 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 19-JAN-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
Initially no symptoms.  But as of date indicated  yesterday first time got a large round swelling 3-4? diameter  (looks like a mosquito bite) that was itchy and felt like a mosquito bite.  Today that swelling is expanding twice in size. Maybe 6??  It is now giving a burning sensation and itchy and painful. My entire body feels lethargic since I woke up and in pain. Also felt I had chills in afternoon and a fever. Could not concentrate or do work, it was heavy symptoms that weren?t letting me sit or do activities for long. Just felt like being in bed.
I had a headache, body and fever since yesterday, Thursday the 17th, I had a headache at dawn, I had a fever and body pain.
stomach cramps; massive diarrhea; nausea; headache; This is a spontaneous report from a contactable consumer (patient). This 72-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot EK9231) via an unspecified route of administration in the left arm on 22Jan2021 at 17:15 (at the age of 72-years-old) as a single dose for COVID-19 immunization. Medical history included anal cancer from 2009 and unknown if ongoing; and cancer Non-Hodgkin's lymph from 1993 and unknown if ongoing. The patient had no allergies to medications, foods or other products. Prior to vaccination the patient was not diagnosed with COVID-19. Concomitant medications included sertraline 100 mg from an unknown date for an unknown indication; rosuvastatin 5 mg from an unknown date for an unknown indication and cetirizine hydrochloride (ZYRTEK) from an unknown date for an unknown indication. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported on the fifth day (27Jan2021) she had stomach cramps, massive diarrhea, nausea and headache and had to lay down; lasting from about 09:00 to 18:00. The events were reported as non-serious and did not require hospitalization. No treatment was provided for the events. The clinical outcomes of stomach cramps, massive diarrhea, nausea and headache were recovered on 27Jan2021 at 18:00. It was also reported the patient was not tested for COVID-19 since vaccination.
10/14 Awoke with low grade temp. 99.6 and severe chills lasting throughout the day. 10/15 Severe chills and sweats throughout the day. 10/16 until present. Muscle inflammation, random muscle spasms and pain throughout my body limiting my strength and mobility. Treatment: 10mg. Cyclobenzaprine every 8 hrs. as needed. 4 mg. Prednisolone dosepk until gone. Acetaminophen-Codeine 1 tablet every six hours as needed for pain. Several visits to my chiropractor.
1 day after injection developed erythema and edema at site, redness extended 2 cm at site. 2 days post injection redness, warmth extended distally to 2 or 3 cm above elbow. 6/17/08-DC Summary received for DOS 3/14-3/16/08-DC DX: left upper arm cellulitis. 6/9/08-records received for DOS 3/15/08-H&P admitted with cellulitis of left upper arm, received vaccinations on 3/12/08, and 8 hours after erythema of left upper arm extending to elbows with swelling and warm to touch was noted. Temperature 100. PE: erythema diffusely macular in nature, no drainage. Nausea.
patient was under 18 years old and pharmacist from a clinic gave a johnson and johnson vaccine to patient. not sure of any reactions but since patient is under age we were instructed to report to VAERS
Patient complains of arm pain and decreased movement or ability to move arm in which shot was given.  There has been no treatment by health care facility at this time.
Patient developed general malaise, local redness, swelling and pain in the area of injection on the left upper arm. Patient was seen by the surgeon, who lanceted and drained the abscess.
I did a multi video play by play over the following hours with updates and changes,  See: (link removed)
A dose past 26 hours punctured today; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A dose past 26 hours punctured today) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A dose past 26 hours punctured today). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A dose past 26 hours punctured today) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.
This case was reported by a pharmacist and described the occurrence of lightheadedness in a subject of unspecified age and gender who was vaccinated with FLULAVAL (GlaxoSmithKline). On 1 October 2013 the subject received a dose of FLULAVAL (unknown details). On 1  October 2013, less than one day after vaccination with FLULAVAL, the subject experienced lightheadedness. Limited information was provided. At the time of reporting the outcome of the event was unspecified.
Patient developed profound weakness in his legs and arms the following day. Had 2 mechanical falls which necessitated activation of EMS to get him off the ground.
Started having diarrhea within a few days after the first shot.  Saw my Dr. and discussed issue with her.  Dr.  recommended that I take probiotics.  Started immediately after my appointment.  Have since changed my diet dramatically.  Still continue to have diarrhea--maybe a 2 day inbetween issues.  Also, after the 2nd dose of Moderna was sick for 24 hours, left arm swelled about 5 inches long with red spots.  That has now subsided.  Diarrhea continues.  Have ordered a new probiotic from MD.